Reta 20mg.
$45.00
Out of stock
Retatrutide is an investigational "triple-agonist" drug (targeting GLP-1, GIP, and glucagon receptors) that shows promising, high-level benefits for obesity and metabolic health.
$45.00
Out of stock
Retatrutide is an investigational "triple-agonist" drug (targeting GLP-1, GIP, and glucagon receptors) that shows promising, high-level benefits for obesity and metabolic health.